Gene editing to induce FOXP3 expression in human CD4


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
03 06 2020
Historique:
received: 05 07 2019
revised: 09 12 2019
accepted: 13 04 2020
entrez: 5 6 2020
pubmed: 5 6 2020
medline: 24 6 2021
Statut: ppublish

Résumé

Thymic regulatory T cells (tT

Identifiants

pubmed: 32493794
pii: 12/546/eaay6422
doi: 10.1126/scitranslmed.aay6422
pii:
doi:

Substances chimiques

FOXP3 protein, human 0
Forkhead Transcription Factors 0
Foxp3 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Yuchi Honaker (Y)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Nicholas Hubbard (N)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Yufei Xiang (Y)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Logan Fisher (L)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA.

David Hagin (D)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Karen Sommer (K)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Yumei Song (Y)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Soo Jung Yang (SJ)

Benaroya Research Institute, Seattle, WA 98101, USA.

Christina Lopez (C)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Tori Tappen (T)

Benaroya Research Institute, Seattle, WA 98101, USA.

Elizabeth M Dam (EM)

Benaroya Research Institute, Seattle, WA 98101, USA.

Iram Khan (I)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Malika Hale (M)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA.

Jane H Buckner (JH)

Benaroya Research Institute, Seattle, WA 98101, USA.
Department of Medicine, University of Washington, Seattle, WA 98101, USA.
Department of Immunology, University of Washington, Seattle, WA 98101, USA.

Andrew M Scharenberg (AM)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA. drawling@uw.edu andrewms@uw.edu.
Department of Immunology, University of Washington, Seattle, WA 98101, USA.
Department of Pediatrics, University of Washington, Seattle, WA 98101, USA.

Troy R Torgerson (TR)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Department of Immunology, University of Washington, Seattle, WA 98101, USA.
Department of Pediatrics, University of Washington, Seattle, WA 98101, USA.

David J Rawlings (DJ)

Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA 98101, USA. drawling@uw.edu andrewms@uw.edu.
Department of Immunology, University of Washington, Seattle, WA 98101, USA.
Department of Pediatrics, University of Washington, Seattle, WA 98101, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH